TYLER, Texas — The University of Texas Health Science Center at Tyler has recently begun research in gene editing aimed at discovering effective new treatments for an array of diseases and infections.
Joining UT Health Science Center at Tyler in late 2019, Dr. Guohua Yi brought along a three-year, $2.25 million National Institutes of Health-funded grant to explore the potential viability of gene editing, or genome engineering, to treat genetic and infectious diseases.
Simply put, gene editing is a group of technologies that provide scientists the ability to change an organism’s DNA. These technologies allow genetic material to be added, removed or altered at particular locations within the genome. While several approaches to genome engineering have been developed, Yi is specifically studying the successful and effective delivery of clustered regularly interspaced short palindromic repeats and associated protein 9 (CRISPR-Cas9) to T cells.
Read more from CBS19's newspaper partner, the Tyler Morning Telegraph.